Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(33%)
Results Posted
50%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_2
1
11%
Ph phase_4
5
56%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
5(55.6%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting3
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 45 (55.6%)
N/A3 (33.3%)

Trials by Status

unknown111%
terminated111%
completed444%
recruiting333%

Recent Activity

3 active trials
Showing 5 of 9
recruitingphase_4

Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

NCT07111559
recruitingphase_4

Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy

NCT05782270
recruitingphase_4

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

NCT06013020
unknownphase_4

Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO

NCT04135677
completedphase_2

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

NCT03273322
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07111559Phase 4

Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

Recruiting
NCT05782270Phase 4

Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy

Recruiting
NCT06013020Phase 4

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

Recruiting
NCT04135677Phase 4

Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO

Unknown
NCT03273322Phase 2

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

Completed
NCT03284827Phase 4

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement

Completed
NCT03218787Not Applicable

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Completed
NCT03355742Not Applicable

XIENCE 28 Global Study

Completed
NCT02224235Not Applicable

COBRA SHIELD OCT Study

Terminated

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9